News & Analysis as of

OxyContin Generic Drugs

Cadwalader, Wickersham & Taft LLP

State Attorney General Insider – Winter 2020-2021 | December 2020 | Issue No. 3: Notable Cases

Notable Cases - Here are a few of the major cases of interest within the state Attorneys General community that are receiving significant press coverage. ...more

Cadwalader, Wickersham & Taft LLP

State Attorney General Insider – Winter 2020-2021, Issue No. 3: Notable Cases

Notable Cases - Here are a few of the major cases of interest within the state Attorneys General community that are receiving significant press coverage. ...more

Robins Kaplan LLP

Purdue Pharma L.P., v. Mylan Pharms. Inc.

Robins Kaplan LLP on

Case Name: Purdue Pharma L.P., v. Mylan Pharms. Inc., 15-1155-RGA-SRF, 2017 U.S. Dist. LEXIS 28460 (D. Del. Mar. 1, 2017) (Fallon, M.J.). Drug Product and Patent(s)-in-Suit: OxyContin® (oxycodone hydrochloride); U.S....more

Robins Kaplan LLP

Purdue Pharma L.P. v. Collegium Pharm., Inc.

Robins Kaplan LLP on

Case Name: Purdue Pharma L.P. v. Collegium Pharm., Inc., 15-260-SLR, 2015 U.S. Dist. LEXIS 102899 (D. Del. Aug. 6, 2015) - Drug Product and Patent-in-Suit: Oxycontin® (oxycodone); U.S. Patents Nos. 7,674,799 ("the '799...more

Robins Kaplan LLP

Purdue Pharma L.P. v. Amneal Pharms., LLC

Robins Kaplan LLP on

Case Name: Purdue Pharma L.P. v. Amneal Pharms., LLC, Civ. Nos. 04-Md-1603 (SHS); 13-cv-3372 (SHS), 2015 U.S. Dist. LEXIS 45967 (S.D.N.Y. Apr. 8, 2015) (Stein, J.) - Drug Product and Patent(s)-in-Suit: OxyContin®...more

5 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide